Dialectical behavior therapy modified for adolescent binge eating disorder: A case report

About this resource

Given the lack of empirically supported treatments available for adolescents with eating disorders, it is important to investigate the clinical utility of extending treatments for adults with eating disorders to younger populations. Dialectical behavior therapy for binge eating disorder, based on the affect-regulation model, conceptualizes binge eating as a behavioral attempt to influence, change, or control painful emotional states. With promising research findings in adult women, it is of clinical interest whether the dialectical behavior therapy for binge eating disorder treatment manual could be usefully adapted for an adolescent population. This report describes adolescent-specific modifications (including the use of family sessions) to standard dialectical behavior therapy for binge eating disorder, with an illustrative case study. While more rigorous case studies are needed prior to establishing justification for a randomized trial, this pilot case provides preliminary support for a modified version of dialectical behavior therapy for binge eating disorder as a therapeutic option for adolescents with binge eating disorder.

AuthorSafer, D. L.; Lock, James & Couturier, Jennifer L.
JournalCognitive and Behavioral Practice

See also

Clinical utility of subtyping binge eating disorder by history of anorexia or bulimia nervosa in a treatment sample

Objective This study examined whether having a history of anorexia nervosa (AN) or bulimia nervosa (BN) is associated with response to treatment in adults with binge eating disorder (BED).

Read more

Estimating the prevalence of binge eating disorder in a community sample from the United States

Objective: To estimate binge eating disorder (BED) prevalence according to DSM-5 and DSM-IV-TR criteria in US adults and to estimate the proportion of individuals meeting DSM-5 BED criteria who reported being formally diagnosed.

Read more

43. Overview of Data Supporting the Efficacy of Lisdexamfetamine Dimesylate in the Treatment of Binge Eating Disorder

The stimulant pro-drug lisdexamfetamine dimesylate (LDX) is the only drug that has regulatory approval for the treatment of binge eating disorder (BED).

Read more

A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: Results of the binge eating and chromium (BEACh) study

Objective Chromium treatment has been shown to improve mood, appetite, and glucose regulation in various psychiatric and medical patient populations.

Read more

Help us improve!

Give us feedback!

We will continue throughout 2020 to update and improve the NEDC website and welcome any feedback you may have on the site.

Provide feedback